A biocatalytic process to obtain optically enriched derivatives of trans-4-(4-fluorophenyl)-3-hydroxymethylpiperidines, based on the enzymatic resolution of racemic precursors of formula III (where R3 is preferably phenyl or benzyl) by acylation of the hydroxyl group. Depending on the enzyme and the reaction conditions, either of the two enantiomers may be obtained with high enantiomeric purity. These compounds are important intermediates in the synthesis of the paroxetine anti-depressive agent.
申请公布号
EP1283200(A3)
申请公布日期
2003.03.05
申请号
EP20020380156
申请日期
2002.07.10
申请人
ASTUR-PHARMA, S.A.;UNIVERSIDAD DE OVIEDO
发明人
BAYOD JASANADA, MICHAEL;SANCHEZ PEDREGA, VICTOR M;GOTOR SANTAMARIA, VICENTE;BRIEVA COLLADO, M. ROSARIO;DE GONZALO CALVO, GONZALO